Jubilant Life Sciences zooms 15% on strong Q3 results

The stock hit a record high of Rs 931, up 15% on BSE after the pharmaceutical company reported a strong 78% year on year jump in consolidated net profit at Rs 2.13 billion in Q3FY18.

Jubilant Life Sciences hit a record high of Rs 931, up 15% on BSE in intra-day trade, after the pharmaceutical company reported a strong 78% year on year(y-o-y) jump in consolidated net profit at Rs 2.13 billion for December 2017 quarter (Q3FY18). The company had profit of Rs 1.18 billion in the same quarter last fiscal.

Consolidated revenue grew 42% at Rs 20.68 billion against Rs 14.91 billion in the corresponding quarter of previous year.

The company has reported highest ever revenue and profitability driven by specialty pharma – injectables business and life science ingredients segment.

Earnings